Author information:
(1)Bella Kaufman and Ronnie Shapira-Frommer, Sheba Medical Center, Tel Hashomer; 
Georgeta Fried, Institute of Oncology, Rambam Health Care Campus; Mariana 
Steiner, Linn Medical Centre, Haifa; Salomon M. Stemmer, Rabin Medical Center, 
Petah Tikva; Ayala Hubert, Hadassah-Hebrew University Hospital, Sharett 
Institute of Oncology; Ora Rosengarten, Shaare Zedek Medical Centre, Jerusalem, 
Israel; Rita K. Schmutzler, Center for Familial Breast and Ovarian Cancer and 
Center of Integrated Oncology, Cologne, Germany; M. William Audeh, Samuel Oschin 
Cancer Institute, Los Angeles, CA; Michael Friedlander, Prince of Wales Clinical 
School, University of New South Wales, Sydney, New South Wales; Gillian 
Mitchell, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, 
Victoria, Australia; Judith Balmaña, Vall d'Hebron Institute of Oncology, 
Barcelona, Spain; Niklas Loman, Skånes Universitetssjuk Lund, Lund, Sweden; 
Karin Bowen and Anitra Fielding, AstraZeneca, Macclesfield, United Kingdom; and 
Susan M. Domchek, Basser Research Center and Abramson Cancer Center, University 
of Pennsylvania, Philadelphia, PA.
(2)Bella Kaufman and Ronnie Shapira-Frommer, Sheba Medical Center, Tel Hashomer; 
Georgeta Fried, Institute of Oncology, Rambam Health Care Campus; Mariana 
Steiner, Linn Medical Centre, Haifa; Salomon M. Stemmer, Rabin Medical Center, 
Petah Tikva; Ayala Hubert, Hadassah-Hebrew University Hospital, Sharett 
Institute of Oncology; Ora Rosengarten, Shaare Zedek Medical Centre, Jerusalem, 
Israel; Rita K. Schmutzler, Center for Familial Breast and Ovarian Cancer and 
Center of Integrated Oncology, Cologne, Germany; M. William Audeh, Samuel Oschin 
Cancer Institute, Los Angeles, CA; Michael Friedlander, Prince of Wales Clinical 
School, University of New South Wales, Sydney, New South Wales; Gillian 
Mitchell, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, 
Victoria, Australia; Judith Balmaña, Vall d'Hebron Institute of Oncology, 
Barcelona, Spain; Niklas Loman, Skånes Universitetssjuk Lund, Lund, Sweden; 
Karin Bowen and Anitra Fielding, AstraZeneca, Macclesfield, United Kingdom; and 
Susan M. Domchek, Basser Research Center and Abramson Cancer Center, University 
of Pennsylvania, Philadelphia, PA. susan.domchek@uphs.upenn.edu.